Sooma launches system for remote clinician-monitored brain stimulation Sooma is proud to announce the launch of its new system for the remote treatment of depression, Sooma Duo. Comprised… Read more
Sooma becomes the first tDCS device manufacturer to receive European MDR certification Sooma is proud to announce that it has received certification that it conforms to the new stringent requirements… Read more
Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment A newly published open-label study, performed at Hospital Psiquiátrico Fray Bernardino Álvarez in Mexico City, demonstrates the remarkable… Read more
Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio At Sooma Medical, we are delighted to announce that the European Patent Office (EPO) has declared… Read more
FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device We are proud to announce the U.S. Food and Drug Administration (FDA) has granted Sooma… Read more
New European Regulation reclassifies brain stimulation equipment without an intended medical purpose as class III Disclaimer: This change does not impact Sooma, Sooma’s customers, or patients using Sooma devices. The… Read more
Sooma’s latest study provides the largest dataset to date on the effects of tDCS for treating MDD in real-world clinical practice Since the publication of our 2019 white paper, we have been working on updating our clinical data regarding the… Read more
Sooma reaches more than 10,000 patients treated with its tDCS devices Mental health crisis is an urgent issue in all countries. More and more patients are becoming chronically ill… Read more
Sooma starts a collaboration with the Non-Invasive Brain Stimulation Lab at University Medical Center (Göttingen) Sooma and the Non-Invasive Brain Stimulation (NBS) Lab have kick-started a collaboration to conduct a clinical trial with 80… Read more
tDCS therapies are now reimbursed in Estonia Psychiatric and neuropathic patients in Estonia can now access tDCS treatments more efficiently, as the Estonian public healthcare system is… Read more
